½ÃÀ庸°í¼­
»óǰÄÚµå
1606319

¼¼°èÀÇ ¼¼Æ÷ äÃë ½ÃÀå : À¯Çüº°, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Cell Harvesting Market by Type (Automated Cell Harvesters, Manual Cell Harvesters), Application (Biopharmaceutical, Stem Cell Research) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼Æ÷ äÃë ½ÃÀåÀº 2023³â¿¡ 21¾ï 8,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 23¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.96%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 39¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼Æ÷ äÃë´Â ÁÖ·Î »ý¸í °øÇÐ, ÀÇÇÐ ¿¬±¸, Ä¡·á µî ´Ù¾çÇÑ ¿ëµµ·Î ±âÁõÀÚ À¯±âü ¶Ç´Â ¹è¾ç ¹èÄ¡¿¡¼­ ¼¼Æ÷¸¦ ¼öÁýÇÏ´Â °úÁ¤À» ¸»ÇÕ´Ï´Ù. Á¶Á÷°ø ÇÐ, »ý¹° Á¦Á¦ÀÇ »ý»ê µîÀÇ Ä¡·á¸¦ °³¹ßÇϴµ¥ À־ ¸Å¿ì Áß¿äÇÑ Àç»ý ÀÇ·áÀÇ ºÐ¾ß°¡ È®´ëµÇ°í ÀÖ´Â °ÍÀ¸·ÎºÎÅÍ »ý°Ü³ª°í ÀÖ½À´Ï´Ù. °¢°¢ â¾à, ÀÓ»ó½ÃÇè, ¸ÂÃãÇü ÀÇ·á µîÀÇ ¿ëµµ¸¦ À§ÇØ ¼¼Æ÷ äÃë ±â¼úÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. Á¤Á¦ °úÁ¤¿¡¼­ Çõ½ÅÀº »ý¸í°øÇп¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó È®Àå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰ ¾÷°è Áõ°¡ÇÏ´Â ¼ö¿ä¿¡ ºÎÀÀ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ƯÈ÷ ¹è¾Æ Áٱ⠼¼Æ÷¸¦ ÀÌ¿ëÇÑ ¼¼Æ÷ äÃë¿¡ ´ëÇÑ À±¸®Àû ¿ì·Á¿Í °í±Þ äÃë ±â¼ú°ú °ü·ÃµÈ ³ôÀº ¿î¿µ ºñ¿ë°ú °°Àº °úÁ¦´Â ¿©ÀüÈ÷ ³²¾Æ ÀÖÀ¸¸ç ƯÈ÷ ½ÅÈï ±¹°¡ ½ÃÀå¿¡¼­ ½ÃÀå ħÅõ¸¦ Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ¾ö°ÝÇÑ Ç°Áú ±âÁØÀÇ Áؼöµµ ÀáÀçÀûÀÎ Àå¾Ö°¡µÇ°í ÀÖ½À´Ï´Ù. ±â¼ú Çõ½Å¿¡ ÃÊÁ¡À» ¸ÂÃß°í ±â¼ú Àú·Å °¡°ÝÀ» °³¼±ÇÏ´Â °ÍÀÌ ¸Å¿ì À¯ÀÍÇÕ´Ï´Ù. äÃëÇÑ ¼¼Æ÷ÀÇ ¼öÀ²°ú »ýÁ¸À²À» ÃÖÀûÈ­ÇÏ´Â ¿¬±¸¿¡ ÁßÁ¡À» µÎ´Â °Íµµ ½ÃÀå ¼ºÀå¿¡ Å©°Ô °øÇåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ¹ßÀü¿¡´Â Çмú ±â°ü °ú ÁÖ¿ä ¾÷°è ¼±¼ö¿ÍÀÇ Áö¼ÓÀûÀÎ Çù·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù. ºñ¿ÁÇÑ ¶¥À» º¸¿©ÁÝ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 21¾ï 8,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 23¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 39¾ï 8,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 8.96%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â ¼¿ ÇϺ£½ºÆÃ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¼¼Æ÷ äÃë ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. È­¿Í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÏ´Â °Í ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¶ÇÇÑ ¼ÒºñÀÚ Çൿ ±×¸®°í ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿¡ À־ ¼ö¿ä Áõ°¡
    • ¼¼Æ÷ ±â¹Ý ¿¬±¸¿Í Ä¡·á¸¦ Áö¿øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼¿ ¼öÈ® Àåºñ ¹× ÀýÂ÷¿¡ ´ëÇÑ ³ôÀº ºñ¿ë ¿ä±¸
  • ½ÃÀå ±âȸ
    • ¼¼Æ÷ äÃë ±â¼ú¿¡ À־ÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸
    • Áٱ⼼Æ÷ ¿¬±¸È°µ¿ ÅõÀÚ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ¼¼Æ÷ äÃë°ú °ü·ÃµÈ À±¸®Àû ¹®Á¦¿Í ±ÔÁ¦»óÀÇ Á¦¾à

Porter's Five Forces : ¼¿ ¼öÈ® ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â ¼¿ ÇϺ£½ºÆÃ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®À» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϰí ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÔÀ¸·Î½á º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼¿ ÇϺ£½ºÆÃ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼¿ ÇϺ£½ºÆÃ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼¿ ¼öÈ® ½ÃÀå¿¡¼­ °æÀï ±¸µµ ÆÄ¾Ç

¼¼Æ÷ äÃë ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¼¿ ÇϺ£½ºÆÃ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼¿ ÇϺ£½ºÆÃ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå ¼¿ ¼öÈ® ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¼¼Æ÷ äÃë ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¹ÙÀÌ¿ÀÀǾàǰ »ý»ê¿¡ À־ ¼ö¿ä Áõ°¡
      • ¼¼Æ÷ ±â¹Ý Á¶»ç ¹× Ä¡·á¸¦ Áö¿øÇÏ´Â Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê
    • ¾ïÁ¦¿äÀÎ
      • ¼¿ ¼öÈ® Àåºñ ¹× ÀýÂ÷¿¡ ´ëÇÑ ³ôÀº ºñ¿ë ¿ä±¸ »çÇ×
    • ±âȸ
      • ¼¼Æ÷ äÃë ±â¼ú¿¡ À־ÀÇ Áö¼ÓÀûÀÎ ±â¼úÀû Áøº¸
      • Áٱ⼼Æ÷ ¿¬±¸ Ȱµ¿¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • °úÁ¦
      • ¼¼Æ÷ äÃë°ú °ü·ÃµÈ À±¸®Àû ¹®Á¦¿Í ±ÔÁ¦»óÀÇ Á¦¾à
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¼¼Æ÷ äÃë ½ÃÀå : À¯Çüº°

  • ÀÚµ¿ ¼¼Æ÷ äÃë ÀåÄ¡
  • ¼öµ¿ ¼¼Æ÷ äÃë ÀåÄ¡

Á¦7Àå ¼¼Æ÷ äÃë ½ÃÀå : ¿ëµµº°

  • ¹ÙÀÌ¿ÀÀǾàǰ
  • Áٱ⼼Æ÷ ¿¬±¸

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼¼Æ÷ äÃë ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼¼Æ÷ äÃë ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼Æ÷ äÃë ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • ADS Biotec, Inc.
  • Angle PLC
  • AVITA Medical, Inc.
  • Corning Incorporated
  • Cytiva by Danaher Corporation
  • Danaher Corporation
  • Esco LifeSciences Group
  • Globus Medical, Inc.
  • Merck KGaA
  • Omnibrx Biotechnology Private Limited
  • PerkinElmer, Inc.
  • Repligen Corporation
  • Sartorius AG
  • ScaleReady LLC
  • Scinomix, Inc.
  • Scorpius BioManufacturing
  • TechnoS Instruments
  • Thermo Fisher Scientific Inc.
  • Tomtec
BJH 24.12.16

The Cell Harvesting Market was valued at USD 2.18 billion in 2023, expected to reach USD 2.34 billion in 2024, and is projected to grow at a CAGR of 8.96%, to USD 3.98 billion by 2030.

Cell harvesting refers to the process of collecting cells from donor organisms or cultured batches for a variety of applications, primarily in biotechnology, medical research, and therapeutic treatments. This necessity arises from the expanding field of regenerative medicine, where harvested cells are pivotal for developing treatments such as stem cell therapies, tissue engineering, and the production of biologics. The end-use scope predominantly spans across hospitals, research institutes, and biopharmaceutical companies, each leveraging cell harvesting techniques for applications like drug discovery, clinical trials, and personalized medicine. The market's growth is chiefly driven by advancements in cell-based research and the increasing prevalence of chronic diseases. Furthermore, technological innovations in cell separation and purification processes, coupled with heightened investments in biotechnology, fuel expansion. Potential opportunities lie in developing automated and scalable harvesting technologies that enhance efficiency and reproducibility, thereby catering to the biopharmaceutical industry's growing demands. However, challenges persist in terms of ethical concerns regarding cell sourcing, particularly with embryonic stem cells, and high operational costs associated with advanced harvesting techniques, which can limit market penetration, especially in developing regions. Moreover, regulatory hurdles and compliance with stringent quality standards remain potential impediments. To overcome these challenges, focusing on innovations in non-invasive cell collection techniques and improving the affordability of technologies can be highly beneficial. Emphasizing research on optimizing the yield and viability of harvested cells would also contribute significantly to market growth. The nature of the market is competitive and evolving, with ongoing collaborations between academic institutions and key industry players being essential for progressing the field. Innovations in biomaterials and bioprocessing technologies represent fertile grounds for exploration to ensure technological advancements align well with ethical standards and economic feasibility.

KEY MARKET STATISTICS
Base Year [2023] USD 2.18 billion
Estimated Year [2024] USD 2.34 billion
Forecast Year [2030] USD 3.98 billion
CAGR (%) 8.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Harvesting Market

The Cell Harvesting Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand in biopharmaceutical production
    • Government initiatives supporting cell-based research and therapies
  • Market Restraints
    • High cost requirement for cell harvesting equipment and procedures
  • Market Opportunities
    • Ongoing technological advancements in cell harvesting techniques
    • Rising investment in stem cell research activities
  • Market Challenges
    • Ethical issues and regulatory constraints associated with cell harvesting

Porter's Five Forces: A Strategic Tool for Navigating the Cell Harvesting Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Harvesting Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Harvesting Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Harvesting Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Harvesting Market

A detailed market share analysis in the Cell Harvesting Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Harvesting Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Harvesting Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Harvesting Market

A strategic analysis of the Cell Harvesting Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Harvesting Market, highlighting leading vendors and their innovative profiles. These include 3M Company, ADS Biotec, Inc., Angle PLC, AVITA Medical, Inc., Corning Incorporated, Cytiva by Danaher Corporation, Danaher Corporation, Esco LifeSciences Group, Globus Medical, Inc., Merck KGaA, Omnibrx Biotechnology Private Limited, PerkinElmer, Inc., Repligen Corporation, Sartorius AG, ScaleReady LLC, Scinomix, Inc., Scorpius BioManufacturing, TechnoS Instruments, Thermo Fisher Scientific Inc., and Tomtec.

Market Segmentation & Coverage

This research report categorizes the Cell Harvesting Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Automated Cell Harvesters and Manual Cell Harvesters.
  • Based on Application, market is studied across Biopharmaceutical and Stem Cell Research.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand in biopharmaceutical production
      • 5.1.1.2. Government initiatives supporting cell-based research and therapies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost requirement for cell harvesting equipment and procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in cell harvesting techniques
      • 5.1.3.2. Rising investment in stem cell research activities
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues and regulatory constraints associated with cell harvesting
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Harvesting Market, by Type

  • 6.1. Introduction
  • 6.2. Automated Cell Harvesters
  • 6.3. Manual Cell Harvesters

7. Cell Harvesting Market, by Application

  • 7.1. Introduction
  • 7.2. Biopharmaceutical
  • 7.3. Stem Cell Research

8. Americas Cell Harvesting Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cell Harvesting Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cell Harvesting Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. ADS Biotec, Inc.
  • 3. Angle PLC
  • 4. AVITA Medical, Inc.
  • 5. Corning Incorporated
  • 6. Cytiva by Danaher Corporation
  • 7. Danaher Corporation
  • 8. Esco LifeSciences Group
  • 9. Globus Medical, Inc.
  • 10. Merck KGaA
  • 11. Omnibrx Biotechnology Private Limited
  • 12. PerkinElmer, Inc.
  • 13. Repligen Corporation
  • 14. Sartorius AG
  • 15. ScaleReady LLC
  • 16. Scinomix, Inc.
  • 17. Scorpius BioManufacturing
  • 18. TechnoS Instruments
  • 19. Thermo Fisher Scientific Inc.
  • 20. Tomtec
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦